-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.00-18.79% Downside
Amneal Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. has been rated by research analysts at Truist Financial, Piper Sandler, Goldman Sachs in the past 90 days.